Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

867
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
867
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
Drug Discovery: Overview01:26

Drug Discovery: Overview

9.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conessine, a steroidal alkaloid from Holarrhena antidysenterica: Ethnomedical roots, pharmacological insights, and formulation strategies for modern drug development.

Steroids·2026
Same author

Blockchain-enabled quality by design system for clinical trials.

Frontiers in medicine·2025
Same author

In Situ Monitoring of Competitive Coformer Exchange Reaction by <sup>1</sup>H MAS Solid-State NMR.

Molecular pharmaceutics·2024
Same author

A critical review of Pongamia pinnata multiple applications: From land remediation and carbon sequestration to socioeconomic benefits.

Journal of environmental management·2022
Same author

The Suitability of Propolis as a Bioactive Component of Biomaterials.

Frontiers in pharmacology·2022
Same author

Fatty Acid Analysis, Chemical Constituents, Biological Activity and Pesticide Residues Screening in Jordanian Propolis.

Molecules (Basel, Switzerland)·2021

Related Experiment Video

Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Towards Pharma 4.0 in clinical trials: A future-orientated perspective.

Reza Ebrahimi Hariry1, Reza Vatankhah Barenji2, Anant Paradkar3

  • 1Department of Pharmacology and Toxicology, Ankara University, Ankara, Turkey; Smart Engineering and Health Research Group, Hacettepe University, Ankara, Turkey.

Drug Discovery Today
|September 19, 2021
PubMed
Summary

Pharma 4.0 enhances drug development through technology integration, improving quality and speed. This study proposes a framework for clinical trials, addressing impacts and barriers for future research.

Keywords:
Artificial intelligenceClinical trialsDrug developmentIndustry 4.0Pharma 4.0

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.1K

Related Experiment Videos

Last Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.1K

Area of Science:

  • Pharmaceutical Sciences
  • Health Informatics
  • Biotechnology

Background:

  • Pharma 4.0, inspired by Industry 4.0, integrates advanced technologies into drug development.
  • Existing conceptualizations of Pharma 4.0 lack clear definitions, particularly in clinical trial applications.
  • Traditional drug development faces challenges in aligning product quality with market speed.

Purpose of the Study:

  • To define and propose a framework for integrating Pharma 4.0 technologies in the clinical trial stage.
  • To analyze the impact and identify barriers to implementing this Pharma 4.0 framework.
  • To explore future research applications and potential of Pharma 4.0 in clinical research.

Main Methods:

  • Review of current computerized technologies used in clinical research.
  • Development of a conceptual framework for Pharma 4.0 integration in clinical trials.
  • Analysis of potential impacts and barriers associated with the proposed framework.

Main Results:

  • Identification of key merged computerized technologies relevant to Pharma 4.0 clinical trials.
  • A proposed framework for integrating Pharma 4.0 technologies into the clinical trial process.
  • Discussion of the significant impacts and challenges in adopting this framework.

Conclusions:

  • The proposed Pharma 4.0 framework offers a pathway to optimize clinical trials.
  • Addressing identified barriers is crucial for successful implementation and realizing potential benefits.
  • Further research is needed to explore the full scope of Pharma 4.0 applications in drug development.